Anti-CHRNB1 monoclonal antibody

Pre-made anti-CHRNB1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CHRNB1/CHRNB1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0545-Ab-1/ GM-Tg-hg-IP0545-Ab-2Anti-Human CHRNB1 monoclonal antibodyHuman
GM-Tg-rg-IP0545-Ab-1/ GM-Tg-rg-IP0545-Ab-2Anti-Rat CHRNB1 monoclonal antibodyRat
GM-Tg-mg-IP0545-Ab-1/ GM-Tg-mg-IP0545-Ab-2Anti-Mouse CHRNB1 monoclonal antibodyMouse
GM-Tg-cynog-IP0545-Ab-1/ GM-Tg-cynog-IP0545-Ab-2Anti-Cynomolgus/ Rhesus macaque CHRNB1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0545-Ab-1/ GM-Tg-felg-IP0545-Ab-2Anti-Feline CHRNB1 monoclonal antibodyFeline
GM-Tg-cang-IP0545-Ab-1/ GM-Tg-cang-IP0545-Ab-2Anti-Canine CHRNB1 monoclonal antibodyCanine
GM-Tg-bovg-IP0545-Ab-1/ GM-Tg-bovg-IP0545-Ab-2Anti-Bovine CHRNB1 monoclonal antibodyBovine
GM-Tg-equg-IP0545-Ab-1/ GM-Tg-equg-IP0545-Ab-2Anti-Equine CHRNB1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0545-Ab-1/ GM-Tg-hg-IP0545-Ab-2; GM-Tg-rg-IP0545-Ab-1/ GM-Tg-rg-IP0545-Ab-2;
GM-Tg-mg-IP0545-Ab-1/ GM-Tg-mg-IP0545-Ab-2; GM-Tg-cynog-IP0545-Ab-1/ GM-Tg-cynog-IP0545-Ab-2;
GM-Tg-felg-IP0545-Ab-1/ GM-Tg-felg-IP0545-Ab-2; GM-Tg-cang-IP0545-Ab-1/ GM-Tg-cang-IP0545-Ab-2;
GM-Tg-bovg-IP0545-Ab-1/ GM-Tg-bovg-IP0545-Ab-2; GM-Tg-equg-IP0545-Ab-1/ GM-Tg-equg-IP0545-Ab-2
Products NameAnti-CHRNB1 monoclonal antibody
Formatmab
Target NameCHRNB1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CHRNB1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0545-Ag-1Recombinant multi-species ACHB/ CHRNB1/ ACHRB protein


    Target information

    Target IDGM-IP0545
    Target NameCHRNB1
    Gene ID1140,11443,24261,715509,489473,101097433,282179,100072990
    Gene Symbol and SynonymsAchr-2,ACHRB,Acrb,CHRNB,CHRNB1,CMS1D,CMS2A,CMS2C,nAChR,RNACRB1,SCCMS
    Uniprot AccessionP11230,P25109,P04758
    Uniprot Entry NameACHB_HUMAN,ACHB_RAT,ACHB_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000170175
    Target ClassificationIon Channel

    The target: CHRNB1, gene name: CHRNB1, also named as ACHRB, CHRNB, CMS1D, CMS2A, CMS2C, SCCMS. The muscle acetylcholine receptor is composed of five subunits: two alpha subunits and one beta, one gamma, and one delta subunit. This gene encodes the beta subunit of the acetylcholine receptor. The acetylcholine receptor changes conformation upon acetylcholine binding leading to the opening of an ion-conducting channel across the plasma membrane. Mutations in this gene are associated with slow-channel congenital myasthenic syndrome. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.